To include your compound in the COVID-19 Resource Center, submit it here.

Tesmilifene: Phase II

YMB completed enrollment in an open-label North American Phase II trial in 29 patients of its

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE